Association between 5-min Apgar score and attention deficit hyperactivity disorder: a Scotland-wide record linkage study of 758,423 school children.
Apgar score
Attention deficit disorder with hyperactivity
Cohort studies
Education
Medical record linkage
Journal
BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559
Informations de publication
Date de publication:
31 10 2023
31 10 2023
Historique:
received:
24
05
2023
accepted:
22
09
2023
medline:
2
11
2023
pubmed:
1
11
2023
entrez:
1
11
2023
Statut:
epublish
Résumé
Attention-deficit hyperactivity disorder (ADHD) affects around 1 in 20 children and is associated with life-long sequelae. Previous studies of the association between Apgar score and ADHD have reported inconsistent findings. Record linkage of maternity, prescribing and school pupil census databases was used to conduct a population e-cohort study of singleton children born in Scotland and attending school in Scotland at any point between 2009 and 2013. Binary logistic regression analysis was used to investigate the association between 5-min Apgar score and treated ADHD adjusting for sociodemographic and maternity confounders. Of the 758,423 children, 7,292 (0.96%) received ADHD medication. The results suggested a potential dose-response relationship between Apgar score and treated ADHD independent of confounders. Referent to an Apgar score of 10, risk of treated ADHD was higher for scores of 0-3 (adjusted OR 1.76, 95% CI 1.32-2.34), 4-6 (adjusted OR 1.50, 95% CI 1.21-1.86) and even 7-9 (adjusted OR 1.26, 95% CI 1.18-1.36) which are traditionally considered within the normal range. In addition to reinforcing the need to maximise Apgar score through good obstetric practice, the findings suggest that Apgar score may be useful in predicting future risk of ADHD and therefore facilitating early diagnosis and treatment.
Sections du résumé
BACKGROUND
Attention-deficit hyperactivity disorder (ADHD) affects around 1 in 20 children and is associated with life-long sequelae. Previous studies of the association between Apgar score and ADHD have reported inconsistent findings.
METHODS
Record linkage of maternity, prescribing and school pupil census databases was used to conduct a population e-cohort study of singleton children born in Scotland and attending school in Scotland at any point between 2009 and 2013. Binary logistic regression analysis was used to investigate the association between 5-min Apgar score and treated ADHD adjusting for sociodemographic and maternity confounders.
RESULTS
Of the 758,423 children, 7,292 (0.96%) received ADHD medication. The results suggested a potential dose-response relationship between Apgar score and treated ADHD independent of confounders. Referent to an Apgar score of 10, risk of treated ADHD was higher for scores of 0-3 (adjusted OR 1.76, 95% CI 1.32-2.34), 4-6 (adjusted OR 1.50, 95% CI 1.21-1.86) and even 7-9 (adjusted OR 1.26, 95% CI 1.18-1.36) which are traditionally considered within the normal range.
CONCLUSIONS
In addition to reinforcing the need to maximise Apgar score through good obstetric practice, the findings suggest that Apgar score may be useful in predicting future risk of ADHD and therefore facilitating early diagnosis and treatment.
Identifiants
pubmed: 37907891
doi: 10.1186/s12888-023-05217-6
pii: 10.1186/s12888-023-05217-6
pmc: PMC10619264
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
794Subventions
Organisme : Medical Research Council
ID : MR/S003800/1
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom
Organisme : Chief Scientist Office
Pays : United Kingdom
Organisme : British Heart Foundation
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Informations de copyright
© 2023. The Author(s).
Références
BJOG. 2012 Jun;119(7):824-31
pubmed: 22571747
Acta Paediatr. 2007 Sep;96(9):1269-74
pubmed: 17718779
Biol Psychiatry. 2012 Mar 1;71(5):474-81
pubmed: 22200325
J Atten Disord. 2018 Jul;22(9):855-863
pubmed: 27095561
Lancet Psychiatry. 2018 Feb;5(2):175-186
pubmed: 29033005
Can J Psychiatry. 2016 May;61(5):283-90
pubmed: 27254803
BMC Psychiatry. 2013 Feb 17;13:59
pubmed: 23414364
Front Med (Lausanne). 2022 Jan 14;8:796544
pubmed: 35096886
Drug Discov Today. 2014 Dec;19(12):1883-96
pubmed: 25256780
J Neurosci. 2000 Jul 15;20(14):5538-43
pubmed: 10884337
Eur J Epidemiol. 2019 Feb;34(2):105-114
pubmed: 30291529
J Child Psychol Psychiatry. 1992 Sep;33(6):1077-90
pubmed: 1400688
Acta Paediatr. 2017 Jun;106(6):944-952
pubmed: 28247426
J Am Acad Child Adolesc Psychiatry. 2012 Oct;51(10):990-1002.e2
pubmed: 23021476
Pediatrics. 2015 Oct;136(4):819-22
pubmed: 26416932
PLoS Med. 2020 Oct 13;17(10):e1003290
pubmed: 33048945
Pediatrics. 2014 Jan;133(1):e14-22
pubmed: 24298003
Pediatrics. 1988 Aug;82(2):240-9
pubmed: 3041363
Psychol Med. 2006 Feb;36(2):159-65
pubmed: 16420712
BMJ. 2019 May 7;365:l1656
pubmed: 31064770
BMJ. 1988 Jul 2;297(6640):24-7
pubmed: 2457406
Eur Child Adolesc Psychiatry. 2004;13 Suppl 1:I7-30
pubmed: 15322953
BMC Public Health. 2022 May 30;22(1):1070
pubmed: 35637502
Anesth Analg. 2015 May;120(5):1056-1059
pubmed: 25899272
BMJ Open. 2019 May 9;9(5):e027655
pubmed: 31072859
Acta Paediatr. 2018 Oct;107(10):1750-1758
pubmed: 29604108
World J Biol Psychiatry. 2011 Sep;12 Suppl 1:124-8
pubmed: 21906010
Front Hum Neurosci. 2015 Jun 24;9:359
pubmed: 26157377
J Pediatr. 1986 Nov;109(5):865-8
pubmed: 3772665
Nord J Psychiatry. 2007;61(1):71-8
pubmed: 17365792
J Pediatr. 2011 May;158(5):775-9
pubmed: 21238979
Dev Med Child Neurol. 2011 Mar;53(3):263-8
pubmed: 20964677
Pediatrics. 2013 Jan;131(1):e53-61
pubmed: 23230063
Arch Gynecol Obstet. 2018 Nov;298(5):889-895
pubmed: 30196359
BJPsych Open. 2023 Jul 17;9(4):e121
pubmed: 37455585
Oxid Med Cell Longev. 2016;2016:9730467
pubmed: 26770661
JAMA Pediatr. 2017 Jul 3;171(7):e170691
pubmed: 28459927
Child Adolesc Psychiatry Ment Health. 2013 Oct 11;7(1):34
pubmed: 24119376
Arch Dis Child Fetal Neonatal Ed. 2016 Mar;101(2):F114-20
pubmed: 26187935